Posts Tagged ‘FDA’

Digital breast tomosynthesis – DBT – has its origins in Holland in the 1930s when the neuroradiologist and electrical engineer George Ziedses […]

April 2021 saw the publication of journal articles that explored the application of artificial intelligence (AI) to breast ultrasound images. […]

Earlier this week in the United States, the Food and Drug Administration (FDA) published an action plan for the use of artificial […]

Two years ago, we introduced a company called QT Ultrasound – where QT stands for “quantitative transmission” – that had just launched three imaging […]

For the past few weeks, there has been understandable excitement that vaccines to inoculate people against the Covid-19 virus have […]

James Dyson is the inventor of the bagless vacuum cleaner and other consumer products, including the Airblade hand dryer, an ultrasonic humidifier […]

Seven years ago, we explored the promise of nanotechnology and highlighted a UK startup called Endomagnetics that had developed a novel product to detect […]

Almost exactly a year ago, on 23 October 2019, CapeRay’s senior management team held an online pre-submission meeting with representatives of the […]

At the beginning of 2020, we highlighted the story of Theranos, manufacturer of a “revolutionary” blood testing system that was supposedly able […]

Twenty years ago, I published a commentary entitled “The professor as entrepreneur” in which I reflected on my decade as an academic […]